XOMA XOMA PE ratio, current and historical analysis
The current PE ratio of XOMA cannot be calculated, as the latest EPS of -$3.44 is negative. XOMA's last PE ratio on record was 20.12 in September 2022.
XOMA PE ratio history
The mean historical PE ratio of XOMA over the last nine years is 43.73. Looking back at the last nine years, XOMA's PE ratio peaked in the Sep 2021 quarter at 130.26, with a price of $24.75 and an EPS of $0.19. The Mar 2018 quarter marked the lowest point at 13.67, with a price of $20.23 and an EPS of $1.48.
XOMA PE ratio by year
Maximum annual decrease: -43.85% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $18.5 | -$4.04 |
| 2022 | N/A | N/A | $18.4 | -$1.98 |
| 2021 | 30.22 | -43.85% | $20.85 | $0.69 |
| 2020 | 53.82 | N/A | $44.13 | $0.82 |
| 2019 | N/A | N/A | $27.3 | -$0.23 |
| 2018 | N/A | N/A | $12.65 | -$1.59 |
| 2017 | 47.47 | N/A | $35.6 | $0.75 |
| 2016 | N/A | N/A | $4.22 | -$8.89 |
| 2015 | N/A | N/A | $26.6 | -$3.5 |
| 2014 | N/A | N/A | $71.8 | -$7.13 |
| 2013 | N/A | N/A | $134.6 | -$28.6 |
| 2012 | N/A | N/A | $48 | -$22 |
| 2011 | N/A | N/A | $23 | -$20.8 |
| 2010 | N/A | N/A | $102.6 | -$73.8 |
| 2009 | 209.64 | N/A | $209.64 | $1 |
XOMA PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | N/A | N/A | $26.48 | -$3.44 |
| Jun 2024 | N/A | N/A | $23.69 | -$2.45 |
| Mar 2024 | N/A | N/A | $24.05 | -$3.92 |
| Dec 2023 | N/A | N/A | $18.5 | -$4.04 |
| Sep 2023 | N/A | N/A | $14.09 | -$2.81 |
| Jun 2023 | N/A | N/A | $18.89 | -$2.69 |
| Mar 2023 | N/A | N/A | $21.11 | -$2.63 |
| Dec 2022 | N/A | N/A | $18.4 | -$1.98 |
| Sep 2022 | 20.12 | -22.35% | $17.91 | $0.89 |
| Jun 2022 | 25.91 | 0% | $22.28 | $0.86 |
| Mar 2022 | 25.91 | -14.26% | $27.98 | $1.08 |
| Dec 2021 | 30.22 | -76.8% | $20.85 | $0.69 |
| Sep 2021 | 130.26 | 129.86% | $24.75 | $0.19 |
| Jun 2021 | 56.67 | -19.46% | $34 | $0.6 |
| Mar 2021 | 70.36 | 30.73% | $40.81 | $0.58 |
XOMA average PE ratio chart
XOMA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| REGN Regeneron Pharmaceuticals Inc | 17.12 | $76.56B |
| NVS Novartis AG | 18.47 | $215.98B |
| PFE Pfizer Inc | 34.61 | $149.04B |
| LLY ELI LILLY & Co | 74.29 | $828.4B |
| ABBV AbbVie Inc | 84.2 | $356.74B |
| EBS Emergent BioSolutions Inc | N/A | $417.76M |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $18.98B |
| XOMA XOMA Corp | N/A | $277.13M |
Frequently asked questions
What is XOMA's PE ratio?
The current price to earnings ratio of XOMA cannot be determined, as its EPS of -$3.44 is negative.
What is the 5-year average PE ratio for XOMA (XOMA)?
The average PE ratio for XOMA stock over the past 5 years is 51.66.
What is the highest PE ratio for XOMA?
Over the last nine years, the quarterly PE ratio reached its highest level at 130.26 in the Sep 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.